$QRVO
Qorvo Inc

2021 Q3 Form 10-Q Financial Statement

#000160477821000042 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q2
Revenue $1.110B $787.5M
YoY Change 1.53%
Cost Of Revenue $564.2M $461.7M
YoY Change -4.08%
Gross Profit $546.2M $325.8M
YoY Change 10.7%
Gross Profit Margin 49.19% 41.37%
Selling, General & Admin $90.30M $86.60M
YoY Change -2.67%
% of Gross Profit 16.53% 26.58%
Research & Development $152.1M $130.1M
YoY Change 9.38%
% of Gross Profit 27.84% 39.92%
Depreciation & Amortization $52.45M $49.99M
YoY Change -21.78%
% of Gross Profit 9.6% 15.34%
Operating Expenses $249.1M $233.1M
YoY Change -2.5%
Operating Profit $297.1M $92.71M
YoY Change 67.88%
Interest Expense $15.28M $18.85M
YoY Change 58.88%
% of Operating Profit 5.14% 20.33%
Other Income/Expense, Net $16.79M $23.14M
YoY Change -2182.54%
Pretax Income $298.6M $97.00M
YoY Change 114.6%
Income Tax $13.00M $100.0K
% Of Pretax Income 4.35% 0.1%
Net Earnings $285.6M $96.92M
YoY Change 145.12%
Net Earnings / Revenue 25.72% 12.31%
Basic Earnings Per Share $2.55 $0.85
Diluted Earnings Per Share $2.51 $0.83
COMMON SHARES
Basic Shares Outstanding 112.0M shares 114.6M shares
Diluted Shares Outstanding 113.9M shares 116.8M shares

Balance Sheet

Concept 2021 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.200B $1.136B
YoY Change 80.48%
Cash & Equivalents $1.200B $1.136B
Short-Term Investments
Other Short-Term Assets $47.76M $38.18M
YoY Change 11.1%
Inventory $570.1M $523.7M
Prepaid Expenses $39.40M $43.80M
Receivables $495.6M $326.0M
Other Receivables $20.95M $11.40M
Total Short-Term Assets $2.374B $2.079B
YoY Change 33.56%
LONG-TERM ASSETS
Property, Plant & Equipment $1.271B $1.236B
YoY Change -5.64%
Goodwill $2.738B $2.615B
YoY Change 13.66%
Intangibles $656.9M $738.3M
YoY Change 45.3%
Long-Term Investments $40.40M $29.90M
YoY Change -69.49%
Other Assets $186.6M $177.2M
YoY Change 15.83%
Total Long-Term Assets $4.898B $4.803B
YoY Change 9.93%
TOTAL ASSETS
Total Short-Term Assets $2.374B $2.079B
Total Long-Term Assets $4.898B $4.803B
Total Assets $7.272B $6.883B
YoY Change 16.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $352.1M $225.9M
YoY Change 0.52%
Accrued Expenses $249.1M $192.4M
YoY Change 14.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.237M $6.587M
YoY Change 280.31%
Total Short-Term Liabilities $703.7M $509.3M
YoY Change 12.65%
LONG-TERM LIABILITIES
Long-Term Debt $1.742B $1.870B
YoY Change 83.54%
Other Long-Term Liabilities $178.2M $152.6M
YoY Change 29.02%
Total Long-Term Liabilities $178.2M $152.6M
YoY Change 29.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $703.7M $509.3M
Total Long-Term Liabilities $178.2M $152.6M
Total Liabilities $2.623B $2.531B
YoY Change 59.31%
SHAREHOLDERS EQUITY
Retained Earnings $404.6M $49.23M
YoY Change -117.49%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.648B $4.351B
YoY Change
Total Liabilities & Shareholders Equity $7.272B $6.883B
YoY Change 16.14%

Cashflow Statement

Concept 2021 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income $285.6M $96.92M
YoY Change 145.12%
Depreciation, Depletion And Amortization $52.45M $49.99M
YoY Change -21.78%
Cash From Operating Activities $341.6M $214.3M
YoY Change -16.66%
INVESTING ACTIVITIES
Capital Expenditures $65.25M $29.83M
YoY Change -40.69%
Acquisitions $166.8M -$155.0K
YoY Change -100.05%
Other Investing Activities -$4.104M -$6.330M
YoY Change -383.09%
Cash From Investing Activities -$228.0M -$23.35M
YoY Change -93.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $300.0M $75.04M
YoY Change -25.02%
Debt Paid & Issued, Net $1.250M $1.250M
YoY Change
Cash From Financing Activities -$311.4M $229.8M
YoY Change 5845.19%
NET CHANGE
Cash From Operating Activities $341.6M $214.3M
Cash From Investing Activities -$228.0M -$23.35M
Cash From Financing Activities -$311.4M $229.8M
Net Change In Cash -$197.8M $421.3M
YoY Change -617.34%
FREE CASH FLOW
Cash From Operating Activities $341.6M $214.3M
Capital Expenditures $65.25M $29.83M
Free Cash Flow $276.3M $184.4M
YoY Change -10.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Entity Registrant Name
EntityRegistrantName
Qorvo, Inc.
CY2021Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001604778
CY2021Q3 dei Document Type
DocumentType
10-Q
CY2021Q3 dei Amendment Flag
AmendmentFlag
false
CY2021Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-02
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
455000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
331000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1609818000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1561613000 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
405000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
405000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
111210000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
112557000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
111210000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112557000 shares
CY2021Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4244740000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29649000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
355036000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
2642708000 USD
CY2021Q3 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
-241000 USD
CY2021Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1161000 USD
CY2021Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
621600000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37400000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72100000 USD
CY2021Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1700000 shares
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300000000.0 USD
CY2021Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1714000000.0 USD
CY2020Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
700000 shares
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75000000.0 USD
CY2021Q3 us-gaap Revenues
Revenues
1110351000 USD
CY2020Q2 us-gaap Revenues
Revenues
787451000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
564168000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
461662000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
152079000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130071000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
90299000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86604000 USD
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6703000 USD
CY2020Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
16402000 USD
CY2021Q3 dei Document Type
DocumentType
10-Q
CY2021Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q3 dei Document Period End Date
DocumentPeriodEndDate
2021-07-03
CY2021Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q3 dei Entity File Number
EntityFileNumber
001-36801
CY2021Q3 dei Entity Registrant Name
EntityRegistrantName
Qorvo, Inc.
CY2021Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5288992
CY2021Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
7628 Thorndike Road
CY2021Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Greensboro,
CY2021Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2021Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27409-9421
CY2021Q3 dei City Area Code
CityAreaCode
336
CY2021Q3 dei Local Phone Number
LocalPhoneNumber
664-1233
CY2021Q3 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2021Q3 dei Trading Symbol
TradingSymbol
QRVO
CY2021Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q3 dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
111141526 shares
CY2021Q2 us-gaap Other Receivables
OtherReceivables
27324000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1200245000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1397880000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
495590000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
457431000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
570144000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
507787000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
39401000 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41572000 USD
CY2021Q3 us-gaap Other Receivables
OtherReceivables
20950000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
47755000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
51810000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
2374085000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
2483804000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1270727000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1266031000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
611155000 USD
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
45939000 USD
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
35370000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
2737626000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
2642708000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
656900000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
186582000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
182402000 USD
CY2021Q3 us-gaap Assets
Assets
7271859000 USD
CY2021Q2 us-gaap Assets
Assets
7221470000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
352143000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
313868000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
249071000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
255060000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
5237000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
5092000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
97257000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
107561000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7221470000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
703708000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
681581000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
1741548000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
1742550000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
178209000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
167914000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
2623465000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
2592045000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4210914000 USD
CY2021Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4244740000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
32918000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29649000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
404562000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
355036000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4648394000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4629425000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7271859000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
152079000 USD
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6703000 USD
CY2021Q3 us-gaap Revenues
Revenues
1110351000 USD
CY2020Q2 us-gaap Revenues
Revenues
787451000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
564168000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
461662000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
546183000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
325789000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130071000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
90299000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86604000 USD
CY2020Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
16402000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
249081000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
233077000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
297102000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
92712000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
15279000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
18849000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16791000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23137000 USD
CY2021Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
298614000 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
97000000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12988000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
285626000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.55
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.51
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112026000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114585000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113872000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116751000 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
285626000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
3238000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
6087000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-31000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-19000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3269000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6106000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
288895000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
103028000 USD
CY2021Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4244740000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29649000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
355036000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4629425000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
285626000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3269000 USD
CY2021Q3 rfmd Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
ExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
-13348000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
17794000 USD
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300017000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25645000 USD
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
111210000 shares
CY2021Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4210914000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
32918000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
404562000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4648394000 USD
CY2020Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4290377000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2288000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
4292665000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6106000 USD
CY2020Q2 rfmd Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
ExerciseOfStockOptionsAndVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
-6065000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
15758000 USD
CY2020Q2 rfmd Cumulativeeffectadoptionof Asu201613
CumulativeeffectadoptionofASU201613
-38000 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75039000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20956000 USD
CY2020Q2 rfmd Other Retained Earnings Adjustment
OtherRetainedEarningsAdjustment
-20000 USD
CY2020Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
4293621000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8394000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
49230000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4351245000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
285626000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
52447000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
49987000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37385000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-41029000 USD
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
60314000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72128000 USD
CY2021Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2000000 USD
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15705000 USD
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
25238000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
21859000 USD
CY2021Q3 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-9487000 USD
CY2020Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-8728000 USD
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35752000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7443000 USD
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11711000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
330000 USD
CY2021Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
54447000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-35329000 USD
CY2021Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-14540000 USD
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
65248000 USD
CY2021Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4104000 USD
CY2020Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-6330000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7588000 USD
CY2021Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-7191000 USD
CY2020Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-7697000 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
341570000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
214281000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29832000 USD
CY2021Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
166818000 USD
CY2020Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-155000 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-227962000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23347000 USD
CY2021Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1250000 USD
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1250000 USD
CY2021Q3 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 USD
CY2020Q2 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
306750000 USD
CY2021Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
300017000 USD
CY2020Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
75039000 USD
CY2021Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9558000 USD
CY2020Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10464000 USD
CY2021Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14371000 USD
CY2020Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7835000 USD
CY2021Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5299000 USD
CY2020Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3249000 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-311379000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
229841000 USD
CY2021Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
507000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
421282000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1398309000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
715612000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1200530000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1136894000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1136894000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1200245000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1136302000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
285000 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
592000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1200530000 USD
CY2021Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
60968000 USD
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
19530000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
162989000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
134959000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
307555000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
283067000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
99600000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
89761000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
570144000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
507787000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
2642708000 USD
CY2021Q3 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
-241000 USD
CY2021Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1161000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
2737626000 USD
CY2021Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
621600000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
40400000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72100000 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
29800000 USD
CY2021Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
14500000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
15700000 USD
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1020048000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
363148000 USD
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1768918000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1157763000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37400000 USD
CY2021Q3 us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
3900000 USD
CY2020Q2 us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
0 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75000000.0 USD
CY2021Q3 rfmd Unamortizedpremiumandissuancecostsnet
Unamortizedpremiumandissuancecostsnet
1435000 USD
CY2021Q2 rfmd Unamortizedpremiumandissuancecostsnet
Unamortizedpremiumandissuancecostsnet
1475000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
5237000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
5092000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
1741548000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
1742550000 USD
CY2021Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
1300000 USD
CY2021Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
16200000 USD
CY2020Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
19900000 USD
CY2021Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1700000 shares
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300000000.0 USD
CY2021Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1714000000.0 USD
CY2020Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
700000 shares
CY2021Q3 us-gaap Revenues
Revenues
1110351000 USD
CY2020Q2 us-gaap Revenues
Revenues
787451000 USD
CY2021Q3 us-gaap Revenues
Revenues
1110351000 USD
CY2020Q2 us-gaap Revenues
Revenues
787451000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
297102000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
92712000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
15279000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
18849000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16791000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23137000 USD
CY2021Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
298614000 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
97000000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000000.0 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.043
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.55
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.51
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2021Q3 us-gaap Revenues
Revenues
1110351000 USD
CY2021Q3 rfmd Discretetaxexpensebenefit
Discretetaxexpensebenefit
20200000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
285626000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
96922000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112026000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114585000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1846000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2166000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113872000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116751000 shares
CY2020Q2 us-gaap Revenues
Revenues
787451000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
564168000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
461662000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
152079000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130071000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
90299000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86604000 USD
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6703000 USD
CY2020Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
16402000 USD

Files In Submission

Name View Source Status
0001604778-21-000042-index-headers.html Edgar Link pending
0001604778-21-000042-index.html Edgar Link pending
0001604778-21-000042.txt Edgar Link pending
0001604778-21-000042-xbrl.zip Edgar Link pending
exhibit2220210703.htm Edgar Link pending
exhibit31120210703.htm Edgar Link pending
exhibit31220210703.htm Edgar Link pending
exhibit32120210703.htm Edgar Link pending
exhibit32220210703.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rfmd-20210703.htm Edgar Link pending
rfmd-20210703.xsd Edgar Link pending
rfmd-20210703_cal.xml Edgar Link unprocessable
rfmd-20210703_def.xml Edgar Link unprocessable
rfmd-20210703_g1.jpg Edgar Link pending
rfmd-20210703_htm.xml Edgar Link completed
rfmd-20210703_lab.xml Edgar Link unprocessable
rfmd-20210703_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending